These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 326573

  • 1. Resistance to parental, allogeneic and xenogeneic hemopoietic grafts in irradiated mice.
    Lotzová E.
    Exp Hematol; 1977 May; 5(3):215-35. PubMed ID: 326573
    [No Abstract] [Full Text] [Related]

  • 2. Hemopoietic cell-defined components of the major histocompatibility complex of mice: identification of responsive and unresponsive recipients for bone marrow transplants.
    Cudkowicz G, Lotzová E.
    Transplant Proc; 1973 Dec; 5(4):1399-405. PubMed ID: 4130054
    [No Abstract] [Full Text] [Related]

  • 3. Involvement of macrophages in genetic resistance to bone marrow grafts. Studies with two specific antimacrophage agents, carrageenan and silica.
    Lotzova E, Gallagher MT, Trentin JJ.
    Biomedicine; 1975 Sep; 22(5):387-92. PubMed ID: 177111
    [Abstract] [Full Text] [Related]

  • 4. Genetic control of resistance to allogeneic and xenogeneic bone-marrow grafts in mice.
    Cudkowicz G.
    Transplant Proc; 1975 Jun; 7(2):155-9. PubMed ID: 165599
    [No Abstract] [Full Text] [Related]

  • 5. Human marrow transplantation--current status.
    Buckner CD, Clift RA, Fefer A, Neiman P, Storb R, Thomas ED.
    Prog Hematol; 1973 Jun; 8():299-324. PubMed ID: 4150971
    [No Abstract] [Full Text] [Related]

  • 6. Allogeneic marrow transplants in cyclophosphamide treated mice.
    Santos GW, Owens AH.
    Transplant Proc; 1969 Mar; 1(1):44-6. PubMed ID: 4400067
    [No Abstract] [Full Text] [Related]

  • 7. Conditioning recipients of hemopoietic cells with antilymphocytic serum (ALS) and partial-body irradiation.
    Kolb H, Thierfelder S, Baumann P, Balk O.
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):810-4. PubMed ID: 4399647
    [No Abstract] [Full Text] [Related]

  • 8. Engraftment of allogeneic dog bone marrow.
    Vriesendorp HM, Zurcher C, van Bekkum DW.
    Transplant Proc; 1975 Dec; 7(4):465-8. PubMed ID: 825
    [Abstract] [Full Text] [Related]

  • 9. The double barrier in bone marrow transplantation.
    van Bekkum DW.
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract] [Full Text] [Related]

  • 10. Hybrid resistance to parental DBA-2 grafts: independence from the H-2 locus. I. Studies with normal hematopoietic cells.
    Cudkowicz G, Rossi GB.
    J Natl Cancer Inst; 1972 Jan; 48(1):131-9. PubMed ID: 4405704
    [No Abstract] [Full Text] [Related]

  • 11. "Xenogeneic resistance" to rat bone marrow transplantation. III. Maturation age, and abrogation with cyclophosphamide, Corynebacterium parvum and fractionated irradiation.
    Rauchwerger JM, Gallagher MT, Monié HJ, Trentin JJ.
    Biomedicine; 1976 Jan; 24(1):20-5. PubMed ID: 773442
    [Abstract] [Full Text] [Related]

  • 12. Resistance of irradiated F 1 hybrid and allogeneic mice to bone marrow grafts of NZB donors.
    Lotzová E, Cudkowicz G.
    J Immunol; 1973 Mar; 110(3):791-800. PubMed ID: 4569800
    [No Abstract] [Full Text] [Related]

  • 13. Bone-marrow transplantation in France, 1958-1973.
    Mathé G, Schwarzenberg L.
    Transplant Proc; 1974 Dec; 6(4):335-43. PubMed ID: 4155150
    [No Abstract] [Full Text] [Related]

  • 14. Bone marrow transplantation: introduction.
    Mathé G, Oldham R.
    Transplant Proc; 1974 Dec; 6(4):333-4. PubMed ID: 4155149
    [No Abstract] [Full Text] [Related]

  • 15. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML, Gozzo JJ, Monaco AP.
    Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
    [No Abstract] [Full Text] [Related]

  • 16. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C, Ilbery PL.
    Exp Hematol; 1973 Dec; 1(1):3-10. PubMed ID: 4154047
    [No Abstract] [Full Text] [Related]

  • 17. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ, Wood ML, Pompei R, Monaco AP.
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract] [Full Text] [Related]

  • 18. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA, Ilbery PL, Motta R.
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.